Northwestern Mutual Wealth Management Co. boosted its holdings in shares of CVS Health Corp (NYSE:CVS) by 4.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 185,719 shares of the pharmacy operator’s stock after buying an additional 8,525 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in CVS Health were worth $14,610,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of CVS. Kiley Juergens Wealth Management LLC boosted its stake in shares of CVS Health by 41.5% during the 3rd quarter. Kiley Juergens Wealth Management LLC now owns 2,270 shares of the pharmacy operator’s stock worth $178,000 after acquiring an additional 666 shares in the last quarter. Northwest Investment Counselors LLC boosted its stake in CVS Health by 2.5% during the 3rd quarter. Northwest Investment Counselors LLC now owns 29,103 shares of the pharmacy operator’s stock valued at $2,291,000 after purchasing an additional 704 shares during the period. Security National Bank of Sioux City Iowa IA boosted its stake in CVS Health by 3.3% during the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 22,523 shares of the pharmacy operator’s stock valued at $1,449,000 after purchasing an additional 720 shares during the period. Twin Capital Management Inc. boosted its stake in CVS Health by 0.7% during the 2nd quarter. Twin Capital Management Inc. now owns 108,530 shares of the pharmacy operator’s stock valued at $6,984,000 after purchasing an additional 730 shares during the period. Finally, Private Capital Group LLC boosted its stake in CVS Health by 11.9% during the 3rd quarter. Private Capital Group LLC now owns 6,851 shares of the pharmacy operator’s stock valued at $539,000 after purchasing an additional 731 shares during the period. 82.42% of the stock is currently owned by hedge funds and other institutional investors.
In other news, EVP Lisa Bisaccia sold 21,534 shares of CVS Health stock in a transaction on Monday, October 1st. The stock was sold at an average price of $80.00, for a total value of $1,722,720.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Kevin Hourican sold 8,564 shares of the firm’s stock in a transaction on Monday, August 27th. The stock was sold at an average price of $75.00, for a total value of $642,300.00. Following the completion of the transaction, the executive vice president now owns 12,135 shares in the company, valued at $910,125. The disclosure for this sale can be found here. Insiders sold a total of 43,409 shares of company stock valued at $3,392,097 over the last three months. Insiders own 0.53% of the company’s stock.
Shares of CVS opened at $79.83 on Friday. CVS Health Corp has a 1 year low of $60.14 and a 1 year high of $83.88. The company has a market capitalization of $80.25 billion, a PE ratio of 13.53, a P/E/G ratio of 1.05 and a beta of 0.98. The company has a quick ratio of 1.87, a current ratio of 2.44 and a debt-to-equity ratio of 1.66.
CVS Health (NYSE:CVS) last released its earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The company had revenue of $47.27 billion during the quarter, compared to analysts’ expectations of $47.22 billion. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same period last year, the firm earned $1.50 EPS. As a group, equities research analysts expect that CVS Health Corp will post 7.04 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th were paid a $0.50 dividend. The ex-dividend date was Tuesday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.51%. CVS Health’s dividend payout ratio (DPR) is currently 33.90%.
A number of analysts have commented on CVS shares. ValuEngine upgraded CVS Health from a “sell” rating to a “hold” rating in a research report on Tuesday. Bank of America raised their price objective on CVS Health from $86.00 to $90.00 and gave the stock a “buy” rating in a research report on Monday, September 17th. Royal Bank of Canada reiterated a “buy” rating and issued a $90.00 price objective on shares of CVS Health in a research report on Wednesday, August 8th. Loop Capital set a $80.00 price objective on CVS Health and gave the stock a “hold” rating in a research report on Friday. Finally, Tigress Financial reiterated a “buy” rating on shares of CVS Health in a research report on Friday, October 26th. One analyst has rated the stock with a sell rating, five have issued a hold rating, ten have given a buy rating and two have issued a strong buy rating to the stock. CVS Health presently has a consensus rating of “Buy” and an average target price of $89.38.
About CVS Health
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Further Reading: Trading Strategy Methods for Individual Investors
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.